2:21 IMRT treatment field delivery time
Name (ID): Z002442-ABD, AAPM (AAPM Z002442-ABD)
Plan or PlanSum ID: 8fld1
Structure ID | Structure Code | Patient Structure | DVH Objective | Evaluator | Variation | Priority | Met | Achieved |
PTV_5200 | PTV_5200 | V52.0Gy[%] | >=95 | 93 | Goal | 95.30 % | ||
PTV_5200 | PTV_5200 | V49.4Gy[%] | >=99 | 97 | Goal | 100.00 % | ||
PTV_5200 | PTV_5200 | D0.03cc[Gy] | <=53 | 56 | Variation | 53.921 Gy | ||
CTV_5200 | CTV_5200 | V52.0Gy[%] | >=99 | 97 | Goal | 100.00 % | ||
PTV4680-PTV5200 | PTV4680-PTV5200 | V46.8Gy[%] | >=95 | 93 | Variation | 94.88 % | ||
PTV4680-PTV5200 | PTV4680-PTV5200 | V44.66Gy[%] | >=99 | 97 | Goal | 99.63 % | ||
CORD | CORD | D0.03cc[Gy] | <45 | Goal | 31.775 Gy | |||
RT KIDNEY | RT KIDNEY | V18.0Gy[%] | <=10 | 50 | Goal | 8.85 % | ||
LT KIDNEY | LT KIDNEY | V18.0Gy[%] | <=0 | 30 | Variation | 1.53 % | ||
BOWEL | BOWEL | V45.0Gy[cc] | <=175 | 250 | Goal | 160.93 cc | ||
LIVER | LIVER | Mean[Gy] | <=5 | 10 | Variation | 5.058 Gy | ||
STOMACH | STOMACH | D25%[Gy] | <=10 | 30 | Goal | 9.966 Gy | ||
PERIPHERAL_RING | PERIPHERAL_RING | V23Gy[cc] | <=20 | 100 | Variation | 46.32 cc |
This nine (9) field IMRT utilized manually selected gantry positions to follow the shape of the target in the transverse view. The biggest challenge in this case proved to be the amount of prescription dose outside of the high dose target (volume of regret) and the metrics assessing max dose (penalty in score above 102% of Rx) and target homogeneity. This plan still featured a max dose <105%, and these strict metrics may or may not be clinically relevant, however challenging to achieve. Even with 1cm leaves (the effect of which was minimized by rotating the collimator to unique angles per gantry position) this plan was still able to retrospectivly achieve a score >80% of the plans submitted to the study.
Both pancreas RT plans were acceptable. The IMRT plan is slightly better. In both cases, the OARs, specifically the bowel. The homogeneity requirements are pretty tight and a priority in this case. These are achieved with good sparing of bowel and kidneys.
3rd party software plan report |
Dosimetric Scorecard |
DICOM patient export |
Any reference to a "plan study" are simply what the organizers call each case and may not be a "study" in the FDA sense as they may not have been published in a peer reviewed journal.
Varian does not provide medical advice and these are illustrative examples only.
Leading plans by expert planner. Your results may vary.
FOR EDUCATIONAL AND SCIENTIFIC EXCHANGE ONLY – NOT FOR SALES OR PROMOTIONAL USE.